(Q40489455)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7689455%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

review article

1 reference

title

Use of the quinolones for the prophylaxis and therapy of infections in immunocompromised hosts (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7689455%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

Use of the Quinolones for the Prophylaxis and Therapy of Infections in Immunocompromised Hosts (English)

1 reference

10.2165/00003495-199300453-00014

Crossref

DOI

https://api.crossref.org/works/10.2165/00003495-199300453-00014

21 August 2024

0 references

1

G. Maschmeyer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7689455

21 August 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7689455

21 August 2024

publication date

1 January 1993

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7689455%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7689455%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

volume

45 Suppl 3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7689455%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

page(s)

73-80

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7689455%20AND%20SRC:MED&resulttype=core&format=json

Ciprofloxacin (intravenous/oral) versus ceftazidime in lower respiratory tract infections

23 October 2019

cites work

1 reference

12 December 2020

Origin of infection in acute nonlymphocytic leukemia. Significance of hospital acquisition of potential pathogens.

1 reference

12 December 2020

Efficacy and safety of pefloxacin in the treatment of severe infections in patients hospitalized in intensive care units

1 reference

12 December 2020

Protective isolation and antimicrobial decontamination in patients with high susceptibility to infection. A prospective cooperative study of gnotobiotic care in acute leukemia patients. I: clinical results

1 reference

12 December 2020

Use of oral antibiotics in protected units environment: clinical effectiveness and role in the emergence of antibiotic-resistant strains.

1 reference

12 December 2020

Infections in cancer patients on a protected environment-prophylactic antibiotic program

1 reference

12 December 2020

Effect of prophylactic measures on the microbial flora of patients in protected environment units

1 reference

12 December 2020

Comparison of norfloxacin with cotrimoxazole for infection prophylaxis in acute leukemia. The trade-off for reduced gram-negative sepsis

1 reference

12 December 2020

CAUSES OF DEATH IN ACUTE LEUKEMIA: A TEN-YEAR STUDY OF 414 PATIENTS FROM 1954-1963

1 reference

12 December 2020

Ciprofloxacin: toxicologic evaluation of additional safety data

1 reference

12 December 2020

Prevention of infection by trimethoprim-sulfamethoxazole plus amphotericin B in patients with acute nonlymphocytic leukaemia

1 reference

12 December 2020

Prophylactic co-trimoxazole versus norfloxacin in neutropenic children--perspective randomized study.

1 reference

12 December 2020

Prospective randomized controlled study of ciprofloxacin versus imipenem-cilastatin in severe clinical infections

1 reference

12 December 2020

Double-blind randomized study of prophylactic trimethoprim/sulfamethoxazole in granulocytopenic patients with hematologic malignancies

1 reference

12 December 2020

Oral norfloxacin for prevention of gram-negative bacterial infections in patients with acute leukemia and granulocytopenia. A randomized, double-blind, placebo-controlled trial

1 reference

12 December 2020

Intravenous ciprofloxacin as empirical treatment of febrile neutropenic patients

1 reference

12 December 2020

Intravenous ciprofloxacin for infections in cancer patients

1 reference

12 December 2020

Safety and immunogenicity of Pseudomonas aeruginosa conjugate A vaccine in cystic fibrosis

1 reference

12 December 2020

Pharmacokinetics of ofloxacin and the effect on the faecal flora of healthy volunteers

1 reference

12 December 2020

A controlled study of isolation and endogenous microbial suppression in acute myelocytic leukemia patients

1 reference

12 December 2020

Non-nephrotoxic empiric antimicrobial therapy in febrile neutropenic cancer patients

1 reference

12 December 2020

Causes of death in adults with acute leukemia

1 reference

12 December 2020

Comparison of the safety and efficacy of intravenous ciprofloxacin and intravenous ceftazidime in the treatment of selected infections

1 reference

12 December 2020

Gastrointestinal "sterilization" in the treatment of patients with acute leukemia.

1 reference

12 December 2020

Symposium on infectious complications of neoplastic disease (Part II). Leukocyte transfusions: thinking twice

1 reference

12 December 2020

Prevention of bacteremia caused by alpha-hemolytic streptococci by roxithromycin (RU-28 965) in granulocytopenic patients receiving ciprofloxacin

1 reference

12 December 2020

Causes of initial remission induction failure in acute myelogenous leukemia.

1 reference

12 December 2020

Effect of oral ofloxacin on fecal bacteria in human volunteers

1 reference

12 December 2020

Treatment of sepsis in patients with neoplastic diseases with intravenous ciprofloxacin

1 reference

12 December 2020

Ofloxacin versus trimethoprim-sulfamethoxazole for prevention of infection in patients with acute leukemia and granulocytopenia

1 reference

12 December 2020

Peripheral neuropathy associated with fluoroquinolones

1 reference

12 December 2020

Prospective, randomized comparison of sequential intravenous followed by oral ciprofloxacin with intravenous ceftazidime in the treatment of serious infections

1 reference

12 December 2020

Comparative effects of enoxacin and norfloxacin on human colonic microflora

1 reference

12 December 2020

Intravenous/oral ciprofloxacin versus ceftazidime in the treatment of serious infections

1 reference

12 December 2020

Intravenous ofloxacin in severe infections

1 reference

12 December 2020

Co-trimoxazole for prevention of infection in acute leukaemia

1 reference

12 December 2020

Infection prophylaxis in neutropenic patients with acute leukaemia--a randomized, comparative study with ofloxacin, ciprofloxacin and co-trimoxazole/colistin

1 reference

12 December 2020

Protection against gram-negative bacteremia and endotoxemia with human monoclonal IgM antibodies

1 reference

12 December 2020

Multicenter, randomized trial of ciprofloxacin plus azlocillin versus ceftazidime plus amikacin for empiric treatment of febrile neutropenic patients

1 reference

12 December 2020

Symposium on infectious complications of neoplastic disease (Part II). Current status of prophylaxis of infection with protected environments

1 reference

12 December 2020

Prospective randomized evaluation of ciprofloxacin versus piperacillin plus amikacin for empiric antibiotic therapy of febrile granulocytopenic cancer patients with lymphomas and solid tumors. The European Organization for Research on Treatment of C

1 reference

12 December 2020

Infectious disease management of adult leukemic patients undergoing chemotherapy: 1982 to 1986 experience at Stanford University Hospital

1 reference

12 December 2020

Selective oral antimicrobial prophylaxis for the prevention of infection in acute leukaemia-ciprofloxacin versus co-trimoxazole plus colistin. The EORTC-Gnotobiotic Project Group

1 reference

12 December 2020

Controlled, comparative study of ciprofloxacin versus ampicillin in treatment of bacterial respiratory tract infections.

1 reference

12 December 2020

Prophylaxis and treatment of infection of the immunocompromised host by granulocyte transfusions.

1 reference

12 December 2020

Ciprofloxacin and norfloxacin for selective decontamination in patients with severe granulocytopenia

1 reference

12 December 2020

Symposium on infectious complications of neoplastic disease (Part II). Protected environments are discomforting and expensive and do not offer meaningful protection

1 reference

12 December 2020

Preliminary evaluation of ciprofloxacin, a new 4-quinolone antibiotic, in the treatment of febrile neutropenic patients

1 reference

12 December 2020

Infection prophylaxis in acute leukemia: a comparison of ciprofloxacin with trimethoprim-sulfamethoxazole and colistin.

1 reference

12 December 2020

The value of protective isolation in preventing nosocomial infections in high risk patients

1 reference

12 December 2020

The role of granulocyte transfusions in treating and preventing infection.

1 reference

12 December 2020

Recovery of norfloxacin in feces after administration of a single oral dose to human volunteers

1 reference

12 December 2020

Prevention of infection in acute leukemia: a prospective randomized study on the efficacy of two different drug regimens for antimicrobial prophylaxis

1 reference

12 December 2020

Infection prophylaxis in acute leukemia. Comparative effectiveness of sulfamethoxazole and trimethoprim, ketoconazole, and a combination of the two

1 reference

12 December 2020

A prospective, randomized comparison of ceftazidime and ciprofloxacin as initial empiric therapy in neutropenic patients with fever

1 reference

12 December 2020

Neutropenia, fever, and infection

1 reference

12 December 2020

Intravenous ciprofloxacin in the treatment of infection in immunocompromised patients

1 reference

12 December 2020

Efficacy of intravenous ofloxacin: a French multicentre trial in 185 patients

1 reference

12 December 2020

Prevention of infection by ciprofloxacin in neutropenia

1 reference

12 December 2020

Norfloxacin versus vancomycin/polymyxin for prevention of infections in granulocytopenic patients

1 reference

12 December 2020

Oral enoxacin for infection prevention in adults with acute nonlymphocytic leukemia. The Enoxacin Prophylaxis Study Group

1 reference

12 December 2020

Effect of norfloxacin on human oropharyngeal and colonic microflora and multiple-dose pharmacokinetics

1 reference

12 December 2020

Treatment of serious infections with intravenous ciprofloxacin. French Multicenter Study Group

1 reference

12 December 2020

Sequential intravenous/oral ciprofloxacin compared with intravenous ceftazidime in the treatment of serious lower respiratory tract infections

1 reference

12 December 2020

The effect of quinolone antibacterials on the gastrointestinal flora compared with that of other antibacterials

1 reference

12 December 2020

Use of immunoglobulins in prevention and treatment of infection in critically ill patients: review and critique

1 reference

12 December 2020

Randomized study of intravenous/oral ciprofloxacin versus ceftazidime in the treatment of hospital and nursing home patients with lower respiratory tract infections

1 reference

12 December 2020

Gut decontamination by oral ofloxacin and ciprofloxacin in healthy volunteers.

1 reference

12 December 2020

Multiple-dose pharmacokinetics and safety of ciprofloxacin in normal volunteers

1 reference

12 December 2020

Prevention of infection during neutropenia.

1 reference

12 December 2020

Severe infections treated with intravenous ofloxacin: a prospective clinical multicentre Swiss study

1 reference

12 December 2020

Randomised comparison of oral ofloxacin alone with combination of parenteral antibiotics in neutropenic febrile patients

1 reference

12 December 2020

Randomized, double-blind comparative study of intravenous ciprofloxacin versus ceftazidime in the treatment of serious infections

1 reference

12 December 2020

Randomized trial comparing ciprofloxacin plus netilmicin versus piperacillin plus netilmicin for empiric treatment of fever in neutropenic patients

1 reference

12 December 2020

Mode of action, and in vitro and in vivo activities of the fluoroquinolones

1 reference

12 December 2020

A comparative study of ofloxacin and amoxycillin/clavulanate in hospitalized patients with lower respiratory tract infections.

1 reference

12 December 2020

The comparative in-vitro activity of ofloxacin

1 reference

12 December 2020

A prospective controlled investigation of prophylactic trimethoprim/sulfamethoxazole in hospitalized granulocytopenic patients

1 reference

12 December 2020

From the Infectious Diseases Society of America. Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever

1 reference

12 December 2020

Safety of intravenous ciprofloxacin. A review

1 reference

12 December 2020

Changes in the pharmacokinetics of ciprofloxacin and fecal flora during administration of a 7-day course to human volunteers

1 reference

12 December 2020

Proceedings: Causes of death in cancer patients

1 reference

12 December 2020

Treatment of respiratory tract infections with ciprofloxacin

1 reference

12 December 2020

Interleukin-1 receptor blockade improves survival and hemodynamic performance in Escherichia coli septic shock, but fails to alter host responses to sublethal endotoxemia

1 reference

12 December 2020